RG

Rakesh Gehlot

Active Director Director DIN 09283963
DIN 09283963 First appointment Aug 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Rakesh Gehlot

Data last updated:

Rakesh Gehlot is a Director at Smarg Healthcare Private Limited (since 2021). The company operates in Trading. Smarg Healthcare Private Limited reported revenue of ₹34,680 (FY 2023).

DIN 09283963
Primary Designation Director
Industry Trading
First Appointment 17 Aug 2021
Oldest Company Age 5 yrs
Largest company Smarg Healthcare Private Limited · ₹34,680 (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Smarg Healthcare Private Limited U51909RJ2021PTC076499
Director17 Aug 20212021₹34,680 (FY 2023)Active

Board colleagues of Rakesh Gehlot

NameDINCompanyDesignation
Jyoti09383699Smarg Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Smarg Healthcare Private Limited
Premium access

Shareholding and investment profile for Rakesh Gehlot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Gehlot

Rakesh Gehlot currently holds 1 directorship: Smarg Healthcare Private Limited (Director, since 17 Aug 2021, revenue ₹34,680 (FY 2023)).

Rakesh Gehlot was first appointed on 17 Aug 2021 as Director at Smarg Healthcare Private Limited.

The current boards of Rakesh Gehlot's companies include Jyoti (Smarg Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available